Anondita Medicare IPO GMP Grey Market Premium

Anondita Medicare IPO GMP is ₹90, estimating a profit of +62.07% on 1 Sept 2025. The IPO was oversubscribed 300.89x times and its allotment status is released on 28 Aug 2025, on the official – Maashitla. The highest grey market premium ever recorded was ₹95, estimating a returns of +65.52% and lowest GMP ever recorded was ₹25, estimating a profit of 17.24% on 20 Aug 2025.

Lowest GMP	Present GMP	Highest GMP	Listing Gains
₹25	₹90	₹95	₹130.5
+17.24%	+62.07%	+65.52%	+90%

Anondita Medicare IPO is a Book Building issue of 47.93 lakh shares aggregating up to ₹69.5 Cr. On NSE SME, the shares are listed at ₹275.50, at a premium of 90% over the issue price of ₹145. However, the expected IPO GMP was just ₹90, and 62.07% profit. Hence, the iporeturns.com Anondita Medicare IPO GMP accuracy is 69%

Anondita Medicare IPO GMP Live Tracker

The following table consists of live updates of Anondita Medicare IPO GMP of last 10 days from the grey market. Investors can check the GMP trends of the IPO shares to understand its demand and decide whether to invest in the Anondita Medicare IPO or to avoid it.

GMP Date	GMP [₹145]	Sub2 Sauda Rate	Est. Profit	Est. Listing Price	IPO Event
1-Sept	₹90	₹68000	62.07%	₹235	Listing
31-Aug	₹90	₹68000	62.07%	₹235
30-Aug	₹85	₹65000	58.62%	₹230
29-Aug	₹80	₹61000	55.17%	₹225
28-Aug	₹95	₹70000	65.52%	₹240	Allotment
27-Aug	₹85	₹63000	58.62%	₹230
26-Aug	₹80	₹60000	55.17%	₹225	Close
25-Aug	₹75	₹55000	51.72%	₹220
24-Aug	₹65	₹50000	44.83%	₹210
23-Aug	₹65	₹50000	44.83%	₹210
22-Aug	₹65	₹50000	44.83%	₹210	Open
21-Aug	₹65	₹50000	44.83%	₹210
20-Aug	₹25	₹21300	17.24%	₹170

What is Anondita Medicare IPO GMP or Grey Market Premium?

Anondita Medicare IPO Grey Market Premium is the premium price paid by investors in grey market for each Anondita Medicare IPO share. The GMP price is the price at which an IPO share is traded in an unregulated and unofficial grey market just before listing of its shares. The grey market premium of Anondita Medicare IPO reflects its demand factor among the investor community. If the GMP is positive, it signals a profitable listing on its listing date. If the GMP is low or negative, then it is expected to be listed at loss or discount and may be avoided by investors

In Anondita Medicare IPO case, the latest available ₹90 over its issue price of ₹145. It is anticipated that, Anondita Medicare IPO shares are expected to list at a premium of +62.07% Profit. However, on listing day, shares of Anondita Medicare are listed at much higher price of ₹235. Hence the Anondita Medicare IPO GMP prediction is valid and accuracy is 69%.

However it should be noted that the Anondita Medicare IPO GMP could be highly volatile and risky. Therefore, before to investing, please consider all factors of the Anondita Medicare IPO and make correct decision before investing in it.

Anondita Medicare IPO GMP Accuracy: 69%

The following table gives complete overview of grey market premium accuracy in terms of Direction Prediction, Return Magnitude and Price Estimation. As per the metrics, the iporeturns GMP accuracy of Anondita Medicare IPO is 69%.

Accuracy Component	Result	Score	Details
Direction Prediction	Correct	100%	Predicted gain, got positive listing (+90%)
Return Magnitude	Underestimated	69%	Predicted +62.07% but actual was +90%
Price Estimation	Good	85.3%	₹235 vs ₹275.50 (₹40.50 underestimate)
iporeturns GMP Accuracy	Fair Performance	69%	Correctly predicted strong positive direction but underestimated explosive gains by 27.93 percentage points

Anondita Medicare IPO Important Dates

IPO Event	Date
IPO Open Date	22-Aug-2025
IPO Close Date	26-Aug-2025
Allotment Date	28-Aug-2025
Refund Date	28-Aug-2025
Credit to DEMAT	29-Aug-2025
IPO Listing Date	1-Sept-2025

Disclaimer: The information provided about Anondita Medicare IPO and its grey market premium (₹90) is for educational and informational purposes only. It should not be considered financial advice or a recommendation to invest. Please consult a qualified financial advisor before making any investment decisions. Investing in the Anondita Medicare IPO or stock market, including IPOs, carries risks, and readers act at their own risk.

About Anondita Medicare Limited Company

Anondita Medicare Limited is a healthcare company based in Noida, Uttar Pradesh, that focuses on manufacturing and marketing contraceptive products. The company is best known for its flagship brand “COBRA”, offering a variety of flavored male condoms in options like strawberry, mint, chocolate, butterscotch, coffee, and bubblegum. With its emphasis on innovation and quality, the brand has gained recognition among both retail consumers and institutional buyers.

The company operates a modern production facility in Noida with an annual manufacturing capacity of around 562 million condoms. This large-scale setup allows Anondita Medicare to cater not only to the Indian market but also to international customers across Southeast Asia, Africa, and the Middle East. Alongside its commercial sales, the company also works with government agencies, NGOs, and health organizations to support public health initiatives.

Over the years, Anondita Medicare has built a strong presence in the contraceptive industry by combining high-quality manufacturing with affordable pricing. Its wide distribution network and growing global reach continue to strengthen its position as a trusted provider of contraceptive products.

Anondita Medicare IPO GMP Grey Market Premium FAQs